Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Clinical trial NCT01597050 · COMPLETED
Trial details
- NCT number
- NCT01597050
- Sponsor
- Rigel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.